4.7 Article

Development of CoMFA and CoMSIA models of cytotoxicity data of anti-HIV-1-phenylamino-1H-imidazole derivatives

期刊

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 44, 期 6, 页码 2400-2407

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2008.09.043

关键词

Amino imidazoles; Anti-HIV; Cytotoxicity data; CoMFA and CoMSIA models

资金

  1. All India Council for Technical Education, New Delhi, India

向作者/读者索取更多资源

3D-QSAR models of 1-Phenylamino-1H-imidazole derivatives with cytotoxic potential have been developed using CoMFA and CoMSIA. Models were built keeping both 10% and 25% of molecules in test set. The Database and Field-Fit alignments were used for CoMFA model development. The best QSAR model was obtained from CoMFA analysis using Database alignment and employing 25% molecules in the test set (r(pred)(2) of 0.91 and r(m)(2) of 0.652). Database alignment with different fields such as Steric (S), Electrostatic (E). Acceptor (A), Donor (D) and Hydrophobic (H) was employed for CoMSIA model development. The best CoMSIA model was obtained by using the SHE fields and employing 25% molecules in the test set (r(pred)(2) of 0.789 and r(m)(2) of 0.410). (C) 2008 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump Inhibition

Mousumi Shyam, Harshita Verma, Gourab Bhattacharje, Piyali Mukherjee, Samsher Singh, Sujit Kamilya, Pushpendu Jalani, Swetarka Das, Arunava Dasgupta, Abhishake Mondal, Amit Kumar Das, Amit Singh, Federico Brucoli, Claire Bagneris, Rachael Dickman, Vinay N. Basavanakatti, Patibandla Naresh Babu, Vadivelan Sankaran, Abhimanyu Dev, Barij Nayan Sinha, Sanjib Bhakta, Venkatesan Jayaprakash

Summary: In this study, pyrazoline analogues were designed and synthesized to mimic the structure of Mycobactin. Compounds 44 and 49 were identified as potential mycobactin biosynthesis inhibitors against mycobacteria, demonstrating effective eradication of intracellular mycobacteria. These compounds also showed stronger efflux pump inhibition compared to known inhibitors. This study provides a new strategy for combating antimicrobial resistance challenges.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Review Chemistry, Medicinal

A Critical Observation on the Design and Development of Reported Peptide Inhibitors of DENV NS2B-NS3 Protease in the Last Two Decades

Sheikh Murtuja, Deepak Shilkar, Biswatrish Sarkar, Barij Nayan Sinha, Venkatesan Jayaprakash

Summary: This article provides a detailed analysis of each case of design and development of peptide inhibitors against DENV NS2B-NS3 protease in the past two decades. The reasons for their inhibitory activity are discussed, and suggestions to improve the inhibitory activity are highlighted whenever possible.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2022)

Review Cardiac & Cardiovascular Systems

Molecular Determinants, Clinical Manifestations and Effects of Immunization on Cardiovascular Health During COVID-19 Pandemic Era- A Review

Amrita Chatterjee, Rajdeep Saha, Arpita Mishra, Deepak Shilkar, Venkatesan Jayaprakash, Pawan Sharma, Biswatrish Sarkar

Summary: Since 2019, the novel coronavirus SARS-CoV-2 has caused an unprecedented pandemic worldwide. It has led to significant damage to multiple organs, including the lungs and heart. The disease is complicated by cardiovascular injury, hypoxia-induced myocardial injury, and systemic inflammatory responses. This review examines the impact of COVID-19 on cardiovascular health, comorbidities, and post-immunization cardiovascular complications.

CURRENT PROBLEMS IN CARDIOLOGY (2023)

Review Pharmacology & Pharmacy

Approaches for targeting the mycobactin biosynthesis pathway for novel anti-tubercular drug discovery: where we stand

Mousumi Shyam, Deepak Shilkar, Gourav Rakshit, Venkatesan Jayaprakash

Summary: This article discusses the opportunities to develop new drugs and prolong the shelf life of existing therapeutics by targeting the conditionally essential pathways inside Mycobacterium. The article emphasizes the bottlenecks in fast-tracking antitubercular drug discovery and proposes some strategies for new drug development.

EXPERT OPINION ON DRUG DISCOVERY (2022)

Article Biochemistry & Molecular Biology

Highly Active Small Aminated Quinolinequinones against Drug-Resistant Staphylococcus aureus and Candida albicans

Hatice Yildirim, Nilufer Bayrak, Mahmut Yildiz, Fatima Nur Yilmaz, Emel Mataraci-Kara, Deepak Shilkar, Venkatesan Jayaprakash, Amac Fatih TuYuN

Summary: Two subseries of aminated quinolinequinones (AQQs) were successfully synthesized, with electron-withdrawing group or electron-donating group in aryl amine moiety. The AQQs with an electron-donating group exhibited strong antibacterial activity against Gram-positive bacterial strains, while the AQQ with an electron-withdrawing group displayed excellent antifungal activity against Candida albicans. In vitro and in silico studies were conducted to explore the mode of action of the selected AQQs.

MOLECULES (2022)

Article Chemistry, Multidisciplinary

Assessment of the CYP1A2 Inhibition-Mediated Drug Interaction Potential for Pinocembrin Using In Silico, In Vitro, and In Vivo Approaches

Shipra Bhatt, Sumit Dhiman, Vinay Kumar, Abhishek Gour, Diksha Manhas, Kuhu Sharma, Probir Kumar Ojha, Utpal Nandi

Summary: Pinocembrin, a potential drug candidate for neurodegenerative diseases, has been found to have a potent inhibitory action on CYP1A2, an enzyme responsible for xenobiotic metabolism. In vitro and in silico studies demonstrate the strong interaction between pinocembrin and CYP1A2, and in vivo investigations using a rat model confirm its potential to cause drug interactions. Further clinical studies are warranted to confirm these findings.

ACS OMEGA (2022)

Article Chemistry, Multidisciplinary

Effect of Myricetin on CYP2C8 Inhibition to Assess the Likelihood of Drug Interaction Using In Silico, In Vitro, and In Vivo Approaches

Shipra Bhatt, Diksha Manhas, Vinay Kumar, Abhishek Gour, Kuhu Sharma, Ashish Dogra, Probir Kumar Ojha, Utpal Nandi

Summary: Myricetin, a bioflavonoid, has shown potent inhibitory effects on CYP2C8 enzyme and may cause drug interactions at the hepatic level. The study suggests that further exploration is needed to avoid adverse effects and optimize anticancer therapy.

ACS OMEGA (2022)

Article Chemistry, Physical

Primer for Designing Main Protease (Mpro) Inhibitors of SARS-CoV-2

Abhishek Thakur, Gaurav Sharma, Vishnu Nayak Badavath, Venkatesan Jayaprakash, Kenneth M. Merz, Galia Blum, Orlando Acevedo

Summary: The COVID-19 outbreak has caused massive devastation worldwide, with millions of infections and deaths reported. Using a combination of crystal structures and validated inhibitors, four rules for designing potent inhibitors of SARS-CoV-2 main protease have been proposed. Experimental examination identified a potential lead compound with higher potency than known inhibitors.

JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2022)

Article Chemistry, Multidisciplinary

Tuberculosis and HIV responses threatened by nCOVID-19: A situation prompting an in silico investigation of reported MbtA inhibitors for combined inhibition of SARS-CoV-2 and HIV-TB co-infection

Gourav Rakshit, Venkatesan Jayaprakash

Summary: This study investigated the potential of a reported antitubercular molecule as an inhibitor for HIV-1 and nCOVID-19, leading to the discovery of a multi-targeted inhibitor for triple co-infections. The results showed strong binding of the molecule to the target proteins, as well as stability throughout the simulation. In silico ADMET results also indicated satisfactory pharmacokinetic properties. Overall, this computational study identified a potential molecule for further exploration and development of inhibitors against triple infections.

STRUCTURAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Exploring the Anticancer Effects of Brominated Plastoquinone Analogs with Promising Cytotoxic Activity in MCF-7 Breast Cancer Cells via Cell Cycle Arrest and Oxidative Stress Induction

Ayse Tarbin Jannuzzi, Ayse Mine Yilmaz Goler, Nilufer Bayrak, Mahmut Yildiz, Hatice Yildirim, Betul Karademir Yilmaz, Deepak Shilkar, Raghusrinivasan Jayaprakash Venkatesan, Venkatesan Jayaprakash, Amac Fatih TuYuN

Summary: Using plastoquinone analogs as lead structures, the investigation of brominated PQ analogs in multiple cancer cell lines has revealed significant growth inhibition effects. These analogs exhibit favorable drug-like properties and have the potential to interact with proteasome catalytic subunits. In vitro assays have shown that brominated PQ analogs induce cytotoxicity by causing cell cycle arrest and oxidative stress. These findings offer valuable insights for the development of novel antiproliferative agents.

PHARMACEUTICALS (2022)

Article Chemistry, Medicinal

Relevance of Machine Learning to Predict the Inhibitory Activity of Small Thiazole Chemicals on Estrogen Receptor

Venkatesan Jayaprakash, Thangavelu Saravanan, Karuppaiyan Ravindran, Thangavelu Prabha, Jubie Selvaraj, Sudeepan Jayapalan, M. V. N. L. Chaitanya, Thangavel Sivakumar

Summary: In this study, a new open-source data analysis Python script was used to discover lead compounds for anticancer drugs by building a QSAR model using 53 thiazole derivatives. Machine learning approaches were employed, and the performance of the model was evaluated using three different algorithms.

CURRENT COMPUTER-AIDED DRUG DESIGN (2023)

Article Chemistry, Multidisciplinary

Aminated Quinolinequinones as Privileged Scaffolds for Antibacterial Agents: Synthesis, In Vitro Evaluation, and Putative Mode of Action

Hatice Yildirim, Nilufer Bayrak, Mahmut Yildiz, Emel Mataraci-Kara, Serol Korkmaz, Deepak Shilkar, Venkatesan Jayaprakash, Amac Faith Tuyun

Summary: This study identified aminated quinolinequinones as potential candidates for novel antibacterial and/or antifungal agents. Some of the compounds demonstrated antimicrobial activity against selected bacterial and fungal strains. AQQ6 and AQQ9 were active against Enterococcus faecalis, while AQQ8 and AQQ9 showed activity against Staphylococcus aureus. AQQ8 and AQQ9 were identified as promising lead molecules for further exploration of their mode of action and antimicrobial activity against biofilm-forming microbes.

ACS OMEGA (2022)

Article Chemistry, Medicinal

A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition

Antonio Laghezza, Carmen Cerchia, Massimo Genovese, Rosalba Leuci, Erica Pranzini, Alice Santi, Leonardo Brunetti, Luca Piemontese, Paolo Tortorella, Abanish Biswas, Ravi Pratap Singh, Suhas Tambe, Sudeep Ca, Ashok Kumar Pattnaik, Venkatesan Jayaprakash, Paolo Paoli, Antonio Lavecchia, Fulvio Loiodice

Summary: A new ligand 10 was identified, which can potently activate both PPAR alpha and -gamma subtypes as full and partial agonists, respectively. Docking studies were performed to explain the different effects on the two targets. In vivo experiments showed that compound 10 significantly reduced blood glucose and lipid levels in diabetic mouse models without toxic effects, and further investigation revealed its inhibitory effect on the mitochondrial pyruvate carrier, suggesting its potential for treating dyslipidemic type 2 diabetes as a new class of drugs.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Carbonic anhydrase inhibitory activity of phthalimide-capped benzene sulphonamide derivatives

Deepak Shilkar, Mohd Usman Mohd Siddique, Silvia Bua, Sabina Yasmin, Mrunali Patil, Ajay Kumar Timiri, Claudiu T. Supuran, Venkatesan Jayaprakash

Summary: A series of phthalimide-capped benzene sulphonamides (1-22) were evaluated for their inhibitory activity against carbonic anhydrase I (hCA I) and carbonic anhydrase II (hCA II). Compound 1 showed potent inhibitory activity against both hCA I (Ki = 28.5 nM) and hCA II (Ki = 2.2 nM), with 10 and 6 times higher potency than the standard inhibitor, acetazolamide. Molecular docking and MD simulations were performed to understand the atomic level interactions responsible for the selectivity of compound 1 towards hCA II.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)

Article Multidisciplinary Sciences

SELEX based aptamers with diagnostic and entry inhibitor therapeutic potential for SARS-CoV-2

Sayanti Halder, Abhishek Thakur, Supriya Suman Keshry, Pradip Jana, Divyanshi Karothia, Indrani Das Jana, Orlando Acevedo, Rajeeb K. Swain, Arindam Mondal, Soma Chattopadhyay, Venkatesan Jayaprakash, Abhimanyu Dev

Summary: The article introduces an aptamer-based system with diagnostic and therapeutic potential against COVID-19. Aptamer R is shown to specifically inhibit the entry of SARS-CoV-2 virus, and its antiviral potential is tested and analyzed. The study also investigates the intermolecular interactions between the aptamers and the virus domain.

SCIENTIFIC REPORTS (2023)

Article Chemistry, Medicinal

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection

Shuang Mei, Su Jiang, Yuting Wang, Han Jing, Peng Yang, Miao-Miao Niu, Jindong Li, Kai Yuan, Yan Zhang

Summary: This study identifies a dual-targeting peptide, AP-1, that effectively inhibits variants of concern (VOCs) of SARS-CoV-2 without impairing host cell viability. The findings suggest that AP-1 could be a promising broad-spectrum agent for treating emerging VOCs of SARS-CoV-2.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of proteolysis-targeting chimera targeting undruggable proteins using a covalent ligand screening approach

Hyeonjun Lee, Ju Yeon Lee, Hyunsoo Jang, Hye Young Cho, Minhee Kang, Sang Hyun Bae, Suin Kim, Eunji Kim, Jaebong Jang, Jin Young Kim, Young Ho Jeon

Summary: By using liquid chromatography-tandem mass spectrometry and nuclear magnetic resonance experiments, we identified new chemical moieties that bind to the target sites of the protein of interest, allowing for reversible binding and protein degradation. This method has the potential to expand the application of PROTAC technology.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A pro-death autophagy-based nanoplatform for enhancing antitumour efficacy with improved immune responses

Yingying Li, Xiyou Du, Xinru Kong, Yuelin Fang, Zhijing He, Dongzhu Liu, Hang Wu, Jianbo Ji, Xiaoye Yang, Lei Ye, Guangxi Zhai

Summary: This study proposes a novel nanoplatform based on the autophagy cascade to overcome the obstacles in chemo-immunotherapy. The platform combines chemotherapy and starvation therapy to initiate pro-death autophagy and enhance antigen presentation, while also remodeling the immunosuppressive tumor microenvironment. Furthermore, the study discovers a new therapeutic direction for the respiration inhibitor 3-bromopyruvic acid (3BP) in cancer treatment. Overall, this study offers an opportunity to improve antitumor efficacy and boost immune responses.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER plus breast cancer

Bingsi Wang, Mingxu Ma, Yusen Dai, Pengfei Yu, Liang Ye, Wenyan Wang, Chunjie Sha, Huijie Yang, Yingjie Yang, Yunjing Zhu, Lin Dong, Shujuan Wei, Linlin Wang, Jingwei Tian, Hongbo Wang

Summary: Breast cancer is a common malignant tumor in women, and drug resistance remains a clinical challenge. In this study, a novel compound, G-5b, was developed with potent antagonistic and degradation activities comparable to the current drug fulvestrant. G-5b also showed improved stability and solubility. Mechanistically, G-5b engages the proteasome pathway to degrade ER, inhibiting the ER signaling pathway and inducing apoptosis and cell cycle arrest. In animal models, G-5b exhibited superior pharmacokinetics and pharmacodynamics properties. Overall, G-5b is a promising long-acting SERD worthy of further investigation and optimization.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents

Karoline B. Waitman, Larissa C. de Almeida, Marina C. Primi, Jorge A. E. G. Carlos, Claudia Ruiz, Thales Kronenberger, Stefan Laufer, Marcia Ines Goettert, Antti Poso, Sandra V. Vassiliades, Vinicius A. M. de Souza, Monica F. Z. J. Toledo, Neuza M. A. Hassimotto, Michael D. Cameron, Thomas D. Bannister, Leticia Costa-Lotufo, Joa o A. Machado-Neto, Mauricio T. Tavares, Roberto Parise-Filho

Summary: A series of hybrid inhibitors combining pharmacophores of known kinase inhibitors and benzohydroxamate HDAC inhibitors were synthesized and evaluated for their anticancer activity and pharmacokinetic properties. Compounds 4d-f exhibited promising cytotoxicity against hematological cells and moderate activity against solid tumor models. Compound 4d showed potent inhibition of multiple kinase targets and had stable interactions with HDAC and members of the JAK family. These compounds showed selective cytotoxicity with minimal effects on non-tumorigenic cells and favorable pharmacokinetic profiles.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Unexpected rearrangement of ivermectin in the synthesis of new derivatives with trypanocidal and antiplasmodial activities

Michal Sulik, Diana Fontinha, Dietmar Steverding, Szymon Sobczak, Michal Antoszczak, Miguel Prudencio, Adam Huczynski

Summary: This study describes the synthesis of the first-in-class ivermectin derivatives obtained through derivatization of the C13 position, along with the unexpected rearrangement of the macrolide ring. These derivatives show potential for antiparasitic activity and are important for the development of new antiparasitic agents.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection

Jun Liu, Qiu-Xian Chen, Wen-Fu Wu, Dong Wang, Si -Yu Zhao, Jia-Hao Li, Yi-Qun Chang, Shao-Gao Zeng, Jia-Yi Hu, Yu-Jie Li, Jia-Xin Du, Shu-Meng Jiao, Hai-Chuan Xiao, Qiang Zhang, Jun Xu, Jian-Fu Zhao, Hai -Bo Zhou, Yong-Heng Wang, Jian Zou, Ping-Hua Sun

Summary: A new anti-infective drug strategy has been discovered to attenuate virulence and modulate inflammation caused by drug-resistant Pseudomonas aeruginosa infections. Compound 5f inhibits biofilm formation, macrophage migration, and inflammatory response induced by P. aeruginosa, showing potential as a novel candidate against drug-resistant infections.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Design and synthesis of pterostilbene derivatives bearing triazole moiety that might treat DSS-induced colitis in mice through modulation of NF-KB/ MAPK signaling pathways

Liuzeng Chen, Ke Wang, Lingyun Wang, Wei Wang, Lifan Wang, Jia Li, Xiaohan Liu, Mengya Wang, Banfeng Ruan

Summary: In this study, a series of novel anti-inflammatory compounds were designed and synthesized based on the natural product pterostilbene skeleton. Among them, compound 8 showed the highest activity and exhibited its effects through inhibition of pro-inflammatory cytokines by blocking the NF-KB/MAPK signaling pathway. Compound 8 also demonstrated a good relieving effect on acute colitis in mice and showed good safety in acute toxicity experiments.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance

Si-Min Liang, Gui-Bin Liang, Hui-Ling Wang, Hong Jiang, Xian-Li Ma, Jian-Hua Wei, Ri-Zhen Huang, Ye Zhang

Summary: A series of novel multi-target antitumor agents were designed, synthesized, and evaluated. Some compounds exhibited significant antitumor activity and one compound showed excellent efficacy, limited toxicity, and low resistance. Further mechanism studies revealed that the compound exerted antitumor effects through multiple pathways.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)